Skip to content

Reducing Aggression Among People With an Intellectual Disability

Reducing Aggressive Behaviour Among People With an Intellectual Disability Through Supplementation of Vitamins, Minerals and n-3 Fatty Acids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03212092
Acronym
PSYVB
Enrollment
137
Registered
2017-07-11
Start date
2018-01-15
Completion date
2021-03-01
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aggression, Intellectual Disability

Keywords

Aggression, aggressive behavior, nutritional supplements, dietary supplements, vitamin, mineral, omega-3, n-3 fatty acids, intellectual disability

Brief summary

The study is an randomised controlled trial (RCT) to test whether supplementation of vitamins, minerals and n-3 fatty acids may reduce aggressive behavior in people with intellectual disabilities.

Detailed description

Rationale: The prevalence of aggression among people with an intellectual disability is high. Previous studies have demonstrated the potential of multivitamin-, mineral-, and n-3 fatty acids (n-3FA) supplementation to reduce antisocial behavior and aggression among schoolchildren and prisoners. Objective: To test the hypothesis that multivitamin-, mineral-, and n-3 FA supplementation reduces aggression among adolescents and young adults with an intellectual disability. Study design: Pragmatic, randomised, double blind, placebo controlled, multicentre intervention study. Study population: People with an intellectual disability aged between 12-39 years, living at a care or treatment facility or having day care, who have shown aggressive behaviour. Intervention: During 16 weeks, people in the active condition receive 4 supplements daily: 2 Bonusan Multi Vital Forte Actief (Multi vitamin and mineral) and 2 Bonusan Omega-3 Forte (n-3 fatty acids) while people in the placebo condition receive 4 placebo capsules. Main study parameters/endpoints: The main study parameter is the number of aggressive incidents from baseline to endpoint (16 weeks post baseline), as measured using the Dutch version of the Modified Overt Aggression Scale (MOAS). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Clients who wish to participate enter a 2-week run-in phase during which they take 4 placebo capsules daily. After positive evaluation of this phase clients are randomised to either the active or control condition. Participants will then start the daily use of 4 supplement capsules or 4 placebo capsules, which continues for 16 weeks. At baseline and endpoint 2 questionnaires will be administered: the Intellectual Disability Quality of Life (IDQOL-16) and the Dutch Healthy Diet Food Frequency Questionnaire (DHD-FFQ). Small hair and faeces samples will be collected at baseline and 16 weeks. The data collection will take less than an hour per client and will take place at the location where the client resides. Aggression incidents will be registered by staff members using the MOAS. Also a staff member will fill in the Social Dysfunction Aggression Scale (SDAS) at baseline and endpoint, measuring observed levels of aggression and social dysfunction. The risks of participating in this study are minimal. The use of the Bonusan Multi Vital Forte Actief, or similar supplements has not been associated with any significant health risks and side effects. Potential benefits of participating in this study is an increase in quality of life through improved nutritional status, as well as a reduction of aggressive incidents. As this is a pragmatic trial in which the main objective is to determine whether the use of supplements has the potential to reduce the number of aggressive incidents among adolescents and young adults with an intellectual disability, it is imperative to include these subjects.

Interventions

DIETARY_SUPPLEMENTMultivitamin, mineral & n-3 FA

The 2 multi vitamin capsules with the two multi vitamin softgel capsules will be handed out once a day during a meal by the staff of the care organization. The compliance will be registered

DIETARY_SUPPLEMENTPlacebo

The placebo of the multi vitamin capsules and the two multi vitamin softgel capsules will be handed out once a day during a meal by the staff of the care organization. The compliance will be registered

Sponsors

Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Placebo with the appearance as the dietary supplements

Intervention model description

The study is a pragmatic multicenter randomized double-blind placebo-controlled intervention trial with an intervention period of 4 months. Since the washout period of several components of dietary supplements is unknown we chose a parallel design.

Eligibility

Sex/Gender
ALL
Age
12 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* intellectual disability * living or day care in a health care organization * age 12 till 39 years * has a at least once a week an aggressive incident.

Exclusion criteria

* Pregnancy * Breastfeeding * people with Williams syndrome, hyperparathyroid or hemochromatosis. * Current use of nutritional supplements and refusal to quit this use for the duration of the study. * Failure to complete the two-week run-in phase. * The use of the following medication: levothyroxine, methyldopa en levodopa

Design outcomes

Primary

MeasureTime frameDescription
AggressionThe aggression will be reported daily by the staff during a period of 18 weeksThe amount of aggressive behavior registered with the Modified Overt Aggression Scale (MOAS).This is a four item aggression scale which distinguishes verbal aggression, aggression to objects, self-aggression and physical aggression to others.

Secondary

MeasureTime frameDescription
Aggression and anti-social behaviorAt baseline and in the 18th weekAggressive- and anti-social behavior measured with the SDAS-11. An eleven item aggression scale. The severity of each item can range from 1 to 5 on a Likert scale.
Quality of Life IDQOL-16At baseline and in the 18th weekQuality of life measured with the IDQOL-16.
Cortisol statusAt baseline and in the 18th weekThe cortisol status measured with hair analyses.
MicrobiomeAt baseline and in the 18th weekThe micobiome measured with feces analysis.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026